Dipiaron took part in the PharmBioTech 2022 - startup competition in the field of biotechnologies and medical technologies, organized by the Skolkovo Innovation center with the support of industrial partners.
After passing the first stage of selection, we got the opportunity to present our project in the final of the competition, where 49 startups entered. The jury members determined 12 winners in 4 nominations. The "Dipiaron" project was named the winner in the nomination "Innovative drugs, biotechnologies, gene and cell technologies".
As the winner of the competition, the company has opportunity to receive mentor and expert support from the Skolkovo and partners, and will also be able to apply for a grant up to 7 million rubles for the refinement and implementation of products (subject to compliance with the requirements of the Found's regulatory documentation)